ESR1 and breast carcinoma: The second problem, breast cancer classification, involves identification of characteristic molecular features that classify 49 primary breast cancer microarray samples as basal (estrogen receptor [ER] negative/androgen receptor [AR] negative), luminal (ER positive/AR positive), or 'molecular apocrine' (ER negative/AR positive) [21].